- Open Access
The pitfalls of bedside regional cerebral oxygen saturation in the early stage of post cardiac arrest
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicinevolume 23, Article number: 95 (2015)
It remains uncertain whether neuromonitoring reliably predicts outcome in adult post-cardiac arrest patients in the early stage treated with therapeutic hypothermia. Recent reports demonstrated a regional cerebral oxygen saturation of cardiac arrest patients on hospital arrival could predict their neurological outcome. There has been little discussion about the significance of regional cerebral oxygen saturation in patients with post-cardiac arrest syndrome. Amplitude-integrated electroencephalography monitoring may also provide early prognostic information for post-cardiac arrest syndrome. However, even when the initial electroencephalography is flat after the return of spontaneous circulation, good neurological outcome may still be obtainable if the electroencephalography shifts to a continuous pattern. The electroencephalography varied from flat to various patterns, such as flat, epileptic, or continuous during the first 24 h, while regional cerebral oxygen saturation levels varied even when the electroencephalography was flat. It is therefore difficult to estimate whether regional cerebral oxygen saturation accurately indicates the coupling of cerebral blood flow and metabolism in the early stage after cardiac arrest. Careful assessment of prognosis is necessary when relying solely on regional cerebral oxygen saturation as a single monitoring modality.
Recent reports demonstrate a relationship between regional cerebral oxygen saturation (rSO2) of cardiac arrest patients on hospital arrival and their neurological outcome [1, 2]. Data are insufficient to support the utility of neuromonitoring for the prediction of outcome of post-cardiac arrest syndrome (PCAS) patients  treated with therapeutic hypothermia. Few reports have discussed the sequential changes or physiological significance of rSO2 during therapeutic hypothermia immediately after the return of spontaneous circulation (ROSC). Monitoring with electroencephalography (EEG) may be able to provide early prognostic information after ROSC in patients with therapeutic hypothermia [4, 5]. Even when EEG indicates a flat pattern in the early stage of ROSC, good neurological outcome may still be obtainable after cardiac arrest if the EEG shifts to a continuous pattern during hypothermia . Yet rSO2 values tend to vary widely even when EEG patterns are flat in the early stage, which makes it difficult to estimate the neurological outcome using only a single modality for monitoring by rSO2.
In this paper we will discuss the clinical pitfalls of rSO2 performed in conjunction with EEG for comatose patients after ROSC.
Clinical issues of rSO2 in patients with PCAS
Theoretically, rSO2 can estimate the balance between the cerebral metabolic rate of oxygen (CMRO2) and cerebral blood flow (CBF), which linearly correlates with cerebral venous oxygen saturation and with CBF . A host of factors such as blood pressure, blood volume, blood viscosity, oxygen delivery/metabolism, and hypo/hypercapnia lead to the vasodilation or constriction of the brain vessels when the cerebral autoregulatory mechanism responds normally,  and cerebral autoregulation keeps the CBF constant in response to changes in these factors. However, the conditions of PCAS have many factors for dysautoregulation such as hypotension and increase or decrease in PaCO2, whereby CBF would be affected by these dysautoregulatory factors. Physicians therefore have to consider many factors when estimating rSO2 values after cardiac arrest. The rSO2 data of brain-dead patients also demonstrates that rSO2 values do not always indicate the cerebral oxygen metabolism . As seen in Fig. 1a, for example, an aEEG pattern can remain flat regardless of the rSO2 value. The rSO2 value may depend on the blood pressure, because CMRO2 is thought be extremely suppressed when the EEG pattern is flat (Fig. 1b, c).
In the experimental model, the EEG was flat after a transient occlusion of both common carotid arteries and gradually changed from a flat to a continuous pattern after the release of the occlusion . In the clinical setting, the EEG is also flat after cardiac arrest and changed from a flat to a various patterns after ROSC . CMRO2 was also initially depressed after ROSC [11, 12]. The balance of CBF and metabolism is significantly altered after ROSC  while CBF might be normal  or decreased  in the resuscitated brain during the 24 h following cardiac arrest. A previous study reports that CMRO2 is not able to predict neurological outcome in the early stage of ROSC . Therefore, the estimation of injured brain or outcome using for rSO2 might need to be carefully assessed in the early stage after PCAS.
Higher rSO2 in the early stage in PCAS
Higher rSO2 values can generally be assumed to have the following pathophysiological significance: hyperemia, including reactive hyperemia (e.g., an increased level of PaCO2), or hyperperfusion (lower CMRO2 and higher CBF). They can also reflect hyperemia caused by severe metabolic depression due to severe brain damage in PCAS. Cerebral oxygen extraction fraction, however, can be expected to decrease in comatose patients immediately after ROSC as a consequence of the primary cerebral metabolic suppression . This appears to be the case even if higher rSO2 levels are detected when the EEG is flat, given that the CMRO2 may be drastically suppressed. Figures 2 and 3 demonstrate an rSO2 level that starts at around 80 % and remains constantly high thereafter. Finally, the aEEG indicated epileptic or suppression-burst EEG patterns of a type thought to portend poor outcome. It was difficult to determine the clinical significance of the high rSO2 values in the early post-resuscitation phase [4–6]. We therefore suspect that high rSO2 values with epileptic or suppression-burst EEG patterns indicate more severe brain damage after cardiac arrest.
Lower rSO2 in the early stage in PCAS
Meanwhile, other factors cause lower rSO2 values in PCAS. The main causes of low rSO2 stem from too little oxygen supply to meet the cerebral oxygen demand, a sign of cerebral ischemia caused by unstable hemodynamics, hypoxia, or decreased PaCO2 rather than a cerebral metabolic suppression. Physicians will be able glean hints for the next steps in their treatment strategies for conditions of these types. Good neurological outcome may be obtainable after PCAS if two conditions are met: first, the patient shows no drastic elevation of rSO2 accompanying an extremely low voltage on the initial EEG; second, the patient shows and no sign of electrographic status epilepticus (Fig. 2) or a suppression-burst pattern (Fig. 3), especially in the early post-resuscitation phase .
A second cause of lower rSO2 values is the continuation of a no-reflow phenomenon suffered by the brain, which is characterized by lack of reperfusion after cerebral ischemia  caused by post-ischemic hypoperfusion, an increase in blood viscosity, a reduction in the caliber of small vessels, or impaired microvascular perfusion [16, 17]. In the results, CBF might be reduced even if blood pressure is within a normal range. Interestingly, no-reflow areas manifested as spotty areas of persistently disturbed recirculation were found to spread from the deep site to the brain surface cortex as the duration of the cardiac arrest increased . This was a point of concern, because the rSO2 probes are placed over the patient’s forehead. We suspect that the presence of a spotty no-reflow area on the brain surface may impede the assessment of the cerebral oxygen metabolism for rSO2 because it measures the hemoglobin oxygen saturation in the regional forebrain cortex.
Continuous monitoring for rSO2 performed in conjunction with EEG for a PCAS patient undergoing therapeutic hypothermia
There has been little discussion about the significance of rSO2 in patients with PCAS who are undergoing therapeutic hypothermia. The normal range of rSO2 in adult PCAS patients treated with therapeutic hypothermia also remains uncertain because of the hypothermic reduction of CMRO2. The amplitude-integrated electroencephalography (aEEG) in PCAS during therapeutic hypothermia was recently classified into four categories: extremely low voltage (flat; maximum voltage < 5 μV); suppression-burst pattern; electrographic status epilepticus with recurrent epileptic form activity; and continuous EEG . Status epilepticus (Fig. 2) and suppression-burst patterns (Fig. 3) on EEG are suggested to have poor outcomes [4–6]. Patterns of these types could be used to predict extensive brain injury after cardiac arrest [4, 5]. Although the initial continuous aEEG pattern was flat (extremely low voltage), we were interested to observe cases in which the aEEG subsequently shifted to a continuous pattern over the following 24 h of therapeutic hypothermia (Fig. 4) and later went on to obtain a good neurological outcome . During the time EEG is flat in the early stage after ROSC, the rSO2 values might be reflected by the influences from factors such as blood pressure, CBF, PaCO2 or no-reflow phenomenon. These result demonstrate that rSO2 alone is insufficient for predicting neurological outcome after PCAS and that rSO2 cannot be confirmed to reliably indicate whether CBF and metabolism are coupling or uncoupling in the early stage after ROSC.
The EEG is extremely suppressed after ROSC and gradually changes to various patterns. CMRO2 might also be initially depressed while the EEG is suppressed. Given the possible therapeutic implications of continuous rSO2 monitoring in patients with brain injury, the variations of rSO2 and potential influences of many factors at this stage made it difficult to determine the clinical significance of rSO2 in PCAS. Careful assessment of prognosis is necessary when relying solely on rSO2 as a single monitoring modality.
Informed consent was obtained from all individual participants included in the study.
This study was approved by the Clinical Research Institutional Review Board (IRB: RK-140613-3) of this hospital.
Post-cardiac arrest syndrome
- rSO2 :
Regional cerebral oxygen saturation
Return of spontaneous circulation
- CMRO2 :
Cerebral metabolic rate of oxygen
Cerebral blood flow
Ito N, Nishiyama K, Callaway CW, Orita T, Hayashida K, Arimoto H, et al. Noninvasive regional cerebral oxygen saturation for neurological prognostication of patients with out-of-hospital cardiac arrest: a prospective multicenter observational study. Resuscitation. 2014;85:778–84.
Hayashida K, Nishiyama K, Suzuki M, Abe T, Orita T, Ito N, et al. Estimated cerebral oxyhemoglobin as a useful indicator of neuroprotection in patients with post-cardiac arrest syndrome: a prospective, multicenter observational study. Crit Care. 2014;18:500.
Nolan JP, Neumar RW, Adrie C, Aibiki M, Berg RA, Böttiger BW, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation. 2008;79:350–79.
Taccone F, Cronberg T, Friberg H, Greer D, Horn J, Oddo M, et al. How to assess prognosis after cardiac arrest and therapeutic hypothermia. Crit Care. 2014;18:202.
Ben-Hamouda N, Taccone FS, Rossetti AO, Oddo M. Contemporary approach to neurologic prognostication of coma after cardiac arrest. Chest. 2014;146:1375–8.
Rundgren M, Westhall E, Cronberg T, Rosén I, Friberg H. Continuous amplitude-integrated electroencephalogram predicts outcome in hypothermia-treated cardiac arrest patients. Crit Care Med. 2010;38:1838–44.
Kurth CD, Levy WJ, McCann J. Near-infrared spectroscopy cerebral oxygen saturation thresholds for hypoxia-ischemia in piglets. J Cereb Blood Flow Metab. 2002;22:335–41.
Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg. 1995;83:949–62.
Schwarz G, Litscher G, Kleinert R, Jobstmann R. Cerebral oximetry in dead subjects. J Neurosurg Anesthesiol. 1996;8:189–93.
Smith ML, Bendek G, Dahlgren N, Rosén I, Wieloch T, Siesjö BK. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand. 1984;69:385–401.
Beckstead JE, Tweed WA, Lee J, MacKeen WL. Cerebral blood flow and metabolism in man following cardiac arrest. Stroke. 1978;9:569–73.
Safar P. Cerebral resuscitation after cardiac arrest: research initiatives and future directions. Ann Emerg Med. 1993;22:324–49.
Safar P, Behringer W, Böttiger BW, Sterz F. Cerebral resuscitation potentials for cardiac arrest. Crit Care Med. 2002;30:S140–4.
Cohan SL, Mun SK, Petite J, Correia J, Tavelra Da Silva AT, Waldhorn RE. Cerebral blood flow in humans following resuscitation from cardiac arrest. Stroke. 1989;20:761–5.
Edgren E, Enblad P, Grenvik A, Lilja A, Valind S, Wiklund L, et al. Cerebral blood flow and metabolism after cardiopulmonary resuscitation. A pathophysiologic and prognostic positron emission tomography pilot study. Resuscitation. 2003;57:161–70.
Fischer M, Hossmann KA. No-reflow after cardiac arrest. Intensive Care Med. 1995;21:132–41.
Ginsberg MD, Myers RE. The topography of impaired microvascular perfusion in the primate brain following total circulatory arrest. Neurology. 1972;22:998–1011.
The authors state that they have no conflict of interest (COI).
K.K. designed, wrote this article. K.K., A.S., and S.I. discussed this comments. K.K. read and approved the final manuscript.